Brian K. Kaspar

Brian K. Kaspar

Center for Gene Therapy, Ohio State University

Affiliated withOhio State University

Research Area

Biography

Brian K. Kaspar has not added Biography.
If you are Brian K. Kaspar and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Intravenous Injections in Neonatal Mice
Publication title

Cited by 78

2014

Other Publications

Article
Year
Targeted retrograde gene delivery for neuronal protection.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 11786045

2002
Adeno-associated virus effectively mediates conditional gene modification in the brain.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 11842206

2002
The adult substantia nigra contains progenitor cells with neurogenic potential.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 12151543

2002
2003
A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 12832526

2003
2003
2004
2005
2005
2005
2006
2006
Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17164329

2006
2006
2007
Gene-targeted therapies for the central nervous system.

Archives of neurology| PubMed ID: 18268183

2008
2008
Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 18334646

2008
Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 18388910

2008
Mesenchymal stem cells as trojan horses for GDNF delivery in ALS.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 19023270

2008
2009
2009
Directed evolution of adeno-associated virus to an infectious respiratory virus.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19237554

2009
2009
2009
2009
Over the barrier and through the blood: to CNS delivery we go.

Cell cycle (Georgetown, Tex.)| PubMed ID: 19949299

2009
2010
2009
Acetylcholine negatively regulates development of the neuromuscular junction through distinct cellular mechanisms.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 20498043

2010
2010
2010
2010
2010
2010
2011
2011
2011
Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 21811247

2011
2011
Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 21876068

2011
2011
Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 22016551

2011
2012
2012
2012
2012
2012
2012
Transplantation of gene-corrected motor neurons as a therapeutic strategy for spinal muscular atrophy.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 23449105

2013
Neural stem cells as a therapeutic approach for amyotrophic lateral sclerosis.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 23449106

2013
2013
Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 23966684

2013
Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 24008656

2013
2014
AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 24162799

2014
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 24379375

2014
Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of Concept.

Annals of clinical and translational neurology| PubMed ID: 24511555

2014
2014
Making sense of pain: are pluripotent stem cell-derived sensory neurons a new tool for studying pain mechanisms?

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 25082088

2014
A Phase I/IIa Follistatin Gene Therapy Trial for Becker Muscular Dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 25322757

2014
Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA - a dose response study in mice and nonhuman primates.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 25358252

2014